Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Mar 1;99(5):1028–1036. doi: 10.1172/JCI119230

Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder.

M R Freeman 1, J J Yoo 1, G Raab 1, S Soker 1, R M Adam 1, F X Schneck 1, A A Renshaw 1, M Klagsbrun 1, A Atala 1
PMCID: PMC507911  PMID: 9062361

Abstract

The epidermal growth factor receptor (HER1) has been implicated in regenerative growth and proliferative diseases of the human bladder epithelium (urothelium), however a cognate HER1 ligand that can act as a growth factor for normal human urothelial cells (HUC) has not been identified. Here we show that heparin-binding EGF-like growth factor (HB-EGF), an activating HER1 ligand, is an autocrine regulator of HUC growth. This conclusion is based on demonstration of HB-EGF synthesis and secretion by primary culture HUC, identification of HER1 as an activatable HB-EGF receptor on HUC surfaces, stimulation of HUC clonal growth by HB-EGF, inhibition of HB-EGF-stimulated growth by heparin and of log-phase growth by CRM 197, a specific inhibitor of HB-EGF/HER1 interaction, and identification of human urothelium as a site of HB-EGF precursor (proHB-EGF) synthesis in vivo. ProHB-EGF expression was also detected in the vascular and detrusor smooth muscle of the human bladder. These data suggest a physiologic role for HB-EGF in the regulation of urothelial proliferation and regeneration subsequent to mucosal injury. Expression of proHB-EGF is also a feature of differentiated vascular and detrusor smooth muscle in the bladder. Because proHB-EGF is known to be the high affinity diphtheria toxin (DT) receptor in human cells, synthesis of the HB-EGF precursor by human urothelium also suggests the possibility of using the DT-binding sites of proHB-EGF as an in vivo target for the intraluminal treatment of urothelial diseases.

Full Text

The Full Text of this article is available as a PDF (382.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aviezer D., Yayon A. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12173–12177. doi: 10.1073/pnas.91.25.12173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beerli R. R., Hynes N. E. Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. J Biol Chem. 1996 Mar 15;271(11):6071–6076. doi: 10.1074/jbc.271.11.6071. [DOI] [PubMed] [Google Scholar]
  3. Besner G., Higashiyama S., Klagsbrun M. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul. 1990 Oct;1(11):811–819. doi: 10.1091/mbc.1.11.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blotnick S., Peoples G. E., Freeman M. R., Eberlein T. J., Klagsbrun M. T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):2890–2894. doi: 10.1073/pnas.91.8.2890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen X., Raab G., Deutsch U., Zhang J., Ezzell R. M., Klagsbrun M. Induction of heparin-binding EGF-like growth factor expression during myogenesis. Activation of the gene by MyoD and localization of the transmembrane form of the protein on the myotube surface. J Biol Chem. 1995 Aug 4;270(31):18285–18294. doi: 10.1074/jbc.270.31.18285. [DOI] [PubMed] [Google Scholar]
  6. Chodak G. W., Hospelhorn V., Judge S. M., Mayforth R., Koeppen H., Sasse J. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer. Cancer Res. 1988 Apr 15;48(8):2083–2088. [PubMed] [Google Scholar]
  7. Chodak G. W., Shing Y., Borge M., Judge S. M., Klagsbrun M. Presence of heparin binding growth factor in mouse bladder tumors and urine from mice with bladder cancer. Cancer Res. 1986 Nov;46(11):5507–5510. [PubMed] [Google Scholar]
  8. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  9. Chopin D. K., Caruelle J. P., Colombel M., Palcy S., Ravery V., Caruelle D., Abbou C. C., Barritault D. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine. J Urol. 1993 Oct;150(4):1126–1130. doi: 10.1016/s0022-5347(17)35705-1. [DOI] [PubMed] [Google Scholar]
  10. Christmas T. J. Lymphocyte sub-populations in the bladder wall in normal bladder, bacterial cystitis and interstitial cystitis. Br J Urol. 1994 May;73(5):508–515. doi: 10.1111/j.1464-410x.1994.tb07635.x. [DOI] [PubMed] [Google Scholar]
  11. Cilento B. G., Freeman M. R., Schneck F. X., Retik A. B., Atala A. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J Urol. 1994 Aug;152(2 Pt 2):665–670. doi: 10.1016/s0022-5347(17)32676-9. [DOI] [PubMed] [Google Scholar]
  12. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986 May 22;89(2):271–277. doi: 10.1016/0022-1759(86)90368-6. [DOI] [PubMed] [Google Scholar]
  13. Dluz S. M., Higashiyama S., Damm D., Abraham J. A., Klagsbrun M. Heparin-binding epidermal growth factor-like growth factor expression in cultured fetal human vascular smooth muscle cells. Induction of mRNA levels and secretion of active mitogen. J Biol Chem. 1993 Aug 25;268(24):18330–18334. [PubMed] [Google Scholar]
  14. Dubeau L., Jones P. A. Growth of normal and neoplastic urothelium and response to epidermal growth factor in a defined serum-free medium. Cancer Res. 1987 Apr 15;47(8):2107–2112. [PubMed] [Google Scholar]
  15. Elgebaly S. A., Allam M. E., Walzak M. P., Jr, Oselinsky D., Gillies C., Yamase H. Urinary neutrophil chemotactic factors in interstitial cystitis patients and a rabbit model of bladder inflammation. J Urol. 1992 May;147(5):1382–1387. doi: 10.1016/s0022-5347(17)37578-x. [DOI] [PubMed] [Google Scholar]
  16. Freeman M. R., Bagli D. J., Lamb C. C., Guthrie P. D., Uchida T., Slavin R. E., Chung L. W. Culture of a prostatic cell line in basement membrane gels results in an enhancement of malignant properties and constitutive alterations in gene expression. J Cell Physiol. 1994 Feb;158(2):325–336. doi: 10.1002/jcp.1041580215. [DOI] [PubMed] [Google Scholar]
  17. Goishi K., Higashiyama S., Klagsbrun M., Nakano N., Umata T., Ishikawa M., Mekada E., Taniguchi N. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell. 1995 Aug;6(8):967–980. doi: 10.1091/mbc.6.8.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Grist M., Chakraborty J. Identification of a mucin layer in the urinary bladder. Urology. 1994 Jul;44(1):26–33. doi: 10.1016/s0090-4295(94)80005-7. [DOI] [PubMed] [Google Scholar]
  19. Hashimoto K., Higashiyama S., Asada H., Hashimura E., Kobayashi T., Sudo K., Nakagawa T., Damm D., Yoshikawa K., Taniguchi N. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes. J Biol Chem. 1994 Aug 5;269(31):20060–20066. [PubMed] [Google Scholar]
  20. Hayashi O., Noguchi S., Oyasu R. Transferrin as a growth factor for rat bladder carcinoma cells in culture. Cancer Res. 1987 Sep 1;47(17):4560–4564. [PubMed] [Google Scholar]
  21. Higashiyama S., Abraham J. A., Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J Cell Biol. 1993 Aug;122(4):933–940. doi: 10.1083/jcb.122.4.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Higashiyama S., Abraham J. A., Miller J., Fiddes J. C., Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 1991 Feb 22;251(4996):936–939. doi: 10.1126/science.1840698. [DOI] [PubMed] [Google Scholar]
  23. Higashiyama S., Iwamoto R., Goishi K., Raab G., Taniguchi N., Klagsbrun M., Mekada E. The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol. 1995 Mar;128(5):929–938. doi: 10.1083/jcb.128.5.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Higashiyama S., Lau K., Besner G. E., Abraham J. A., Klagsbrun M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem. 1992 Mar 25;267(9):6205–6212. [PubMed] [Google Scholar]
  25. Hirao Y., Izumi K., Oyasu R. The effect of normal rat urine on mucosal regeneration in heterotopic urinary bladder. Lab Invest. 1980 Jan;42(1):76–84. [PubMed] [Google Scholar]
  26. Imai T., Kimura M., Takeda M., Tomita Y. Significance of epidermal growth factor receptor and c-erbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumour recurrence at the urinary bladder. Br J Cancer. 1995 Jan;71(1):69–72. doi: 10.1038/bjc.1995.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Iwamoto R., Higashiyama S., Mitamura T., Taniguchi N., Klagsbrun M., Mekada E. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 1994 May 15;13(10):2322–2330. doi: 10.1002/j.1460-2075.1994.tb06516.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kuranami M., Yamaguchi K., Fuchigami M., Imanishi K., Watanabe T., Abe K., Asanuma F., Hiki Y. Effect of urine on clonal growth of human bladder cancer cell lines. Cancer Res. 1991 Sep 1;51(17):4631–4635. [PubMed] [Google Scholar]
  29. Lau J. L., Fowler J. E., Jr, Ghosh L. Epidermal growth factor in the normal and neoplastic kidney and bladder. J Urol. 1988 Jan;139(1):170–175. doi: 10.1016/s0022-5347(17)42347-0. [DOI] [PubMed] [Google Scholar]
  30. Marikovsky M., Breuing K., Liu P. Y., Eriksson E., Higashiyama S., Farber P., Abraham J., Klagsbrun M. Appearance of heparin-binding EGF-like growth factor in wound fluid as a response to injury. Proc Natl Acad Sci U S A. 1993 May 1;90(9):3889–3893. doi: 10.1073/pnas.90.9.3889. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Martin B. F. Cell replacement and differentiation in transitional epithelium: a histological and autoradiographic study of the guinea-pig bladder and ureter. J Anat. 1972 Sep;112(Pt 3):433–455. [PMC free article] [PubMed] [Google Scholar]
  32. Masui H., Wells A., Lazar C. S., Rosenfeld M. G., Gill G. N. Enhanced tumorigenesis of NR6 cells which express non-down-regulating epidermal growth factor receptors. Cancer Res. 1991 Nov 15;51(22):6170–6175. [PubMed] [Google Scholar]
  33. Mellon K., Wright C., Kelly P., Horne C. H., Neal D. E. Long-term outcome related to epidermal growth factor receptor status in bladder cancer. J Urol. 1995 Mar;153(3 Pt 2):919–925. [PubMed] [Google Scholar]
  34. Mesri E. A., Ono M., Kreitman R. J., Klagsbrun M., Pastan I. The heparin-binding domain of heparin-binding EGF-like growth factor can target Pseudomonas exotoxin to kill cells exclusively through heparan sulfate proteoglycans. J Cell Sci. 1994 Sep;107(Pt 9):2599–2608. doi: 10.1242/jcs.107.9.2599. [DOI] [PubMed] [Google Scholar]
  35. Messing E. M., Hanson P., Ulrich P., Erturk E. Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol. 1987 Nov;138(5):1329–1335. doi: 10.1016/s0022-5347(17)43593-2. [DOI] [PubMed] [Google Scholar]
  36. Messing E. M., Reznikoff C. A. Normal and malignant human urothelium: in vitro effects of epidermal growth factor. Cancer Res. 1987 May 1;47(9):2230–2235. [PubMed] [Google Scholar]
  37. Mitamura T., Higashiyama S., Taniguchi N., Klagsbrun M., Mekada E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J Biol Chem. 1995 Jan 20;270(3):1015–1019. doi: 10.1074/jbc.270.3.1015. [DOI] [PubMed] [Google Scholar]
  38. Miyagawa J., Higashiyama S., Kawata S., Inui Y., Tamura S., Yamamoto K., Nishida M., Nakamura T., Yamashita S., Matsuzawa Y. Localization of heparin-binding EGF-like growth factor in the smooth muscle cells and macrophages of human atherosclerotic plaques. J Clin Invest. 1995 Jan;95(1):404–411. doi: 10.1172/JCI117669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Momose H., Kakinuma H., Shariff S. Y., Mitchell G. B., Rademaker A., Oyasu R. Tumor-promoting effect of urinary epidermal growth factor in rat urinary bladder carcinogenesis. Cancer Res. 1991 Oct 15;51(20):5487–5490. [PubMed] [Google Scholar]
  40. Naglich J. G., Metherall J. E., Russell D. W., Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell. 1992 Jun 12;69(6):1051–1061. doi: 10.1016/0092-8674(92)90623-k. [DOI] [PubMed] [Google Scholar]
  41. Nakamura K., Iwamoto R., Mekada E. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J Cell Biol. 1995 Jun;129(6):1691–1705. doi: 10.1083/jcb.129.6.1691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Nguyen M., Watanabe H., Budson A. E., Richie J. P., Folkman J. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J Natl Cancer Inst. 1993 Feb 3;85(3):241–242. doi: 10.1093/jnci/85.3.241. [DOI] [PubMed] [Google Scholar]
  43. Nguyen P. L., Swanson P. E., Jaszcz W., Aeppli D. M., Zhang G., Singleton T. P., Ward S., Dykoski D., Harvey J., Niehans G. A. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis. Am J Clin Pathol. 1994 Feb;101(2):166–176. doi: 10.1093/ajcp/101.2.166. [DOI] [PubMed] [Google Scholar]
  44. Noguchi S., Yura Y., Sherwood E. R., Kakinuma H., Kashihara N., Oyasu R. Stimulation of stromal cell growth by normal rat urothelial cell-derived epidermal growth factor. Lab Invest. 1990 May;62(5):538–544. [PubMed] [Google Scholar]
  45. Oyasu R., Hirao Y., Izumi K. Enhancement by urine of urinary bladder carcinogenesis. Cancer Res. 1981 Feb;41(2):478–481. [PubMed] [Google Scholar]
  46. Parries G., Chen K., Misono K. S., Cohen S. The human urinary epidermal growth factor (EGF) precursor. Isolation of a biologically active 160-kilodalton heparin-binding pro-EGF with a truncated carboxyl terminus. J Biol Chem. 1995 Nov 17;270(46):27954–27960. doi: 10.1074/jbc.270.46.27954. [DOI] [PubMed] [Google Scholar]
  47. Parsons C. L. A model for the function of glycosaminoglycans in the urinary tract. World J Urol. 1994;12(1):38–42. doi: 10.1007/BF00182049. [DOI] [PubMed] [Google Scholar]
  48. Peoples G. E., Blotnick S., Takahashi K., Freeman M. R., Klagsbrun M., Eberlein T. J. T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role. Proc Natl Acad Sci U S A. 1995 Jul 3;92(14):6547–6551. doi: 10.1073/pnas.92.14.6547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Powell P. P., Klagsbrun M., Abraham J. A., Jones R. C. Eosinophils expressing heparin-binding EGF-like growth factor mRNA localize around lung microvessels in pulmonary hypertension. Am J Pathol. 1993 Sep;143(3):784–793. [PMC free article] [PubMed] [Google Scholar]
  50. Raab G., Higashiyama S., Hetelekidis S., Abraham J. A., Damm D., Ono M., Klagsbrun M. Biosynthesis and processing by phorbol ester of the cells surface-associated precursor form of heparin-binding EGF-like growth factor. Biochem Biophys Res Commun. 1994 Oct 28;204(2):592–597. doi: 10.1006/bbrc.1994.2500. [DOI] [PubMed] [Google Scholar]
  51. Ravery V., Colombel M., Popov Z., Bastuji S., Patard J. J., Bellot J., Abbou C. C., Fradet Y., Chopin D. K. Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer. Br J Cancer. 1995 Jan;71(1):196–200. doi: 10.1038/bjc.1995.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Rolf J. M., Gaudin H. M., Eidels L. Localization of the diphtheria toxin receptor-binding domain to the carboxyl-terminal Mr approximately 6000 region of the toxin. J Biol Chem. 1990 May 5;265(13):7331–7337. [PubMed] [Google Scholar]
  53. Rowland R. G., Henneberry M. O., Oyasu R., Grayhack J. T. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions. Cancer Res. 1980 Dec;40(12):4524–4527. [PubMed] [Google Scholar]
  54. Sauter G., Haley J., Chew K., Kerschmann R., Moore D., Carroll P., Moch H., Gudat F., Mihatsch M. J., Waldman F. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer. 1994 May 15;57(4):508–514. doi: 10.1002/ijc.2910570412. [DOI] [PubMed] [Google Scholar]
  55. Shishido Y., Sharma K. D., Higashiyama S., Klagsbrun M., Mekada E. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor/membrane-anchored heparin-binding epidermal growth factor-like growth factor. J Biol Chem. 1995 Dec 8;270(49):29578–29585. doi: 10.1074/jbc.270.49.29578. [DOI] [PubMed] [Google Scholar]
  56. Soker S., Fidder H., Neufeld G., Klagsbrun M. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J Biol Chem. 1996 Mar 8;271(10):5761–5767. doi: 10.1074/jbc.271.10.5761. [DOI] [PubMed] [Google Scholar]
  57. Temizer D. H., Yoshizumi M., Perrella M. A., Susanni E. E., Quertermous T., Lee M. E. Induction of heparin-binding epidermal growth factor-like growth factor mRNA by phorbol ester and angiotensin II in rat aortic smooth muscle cells. J Biol Chem. 1992 Dec 5;267(34):24892–24896. [PubMed] [Google Scholar]
  58. Yoshizumi M., Kourembanas S., Temizer D. H., Cambria R. P., Quertermous T., Lee M. E. Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J Biol Chem. 1992 May 15;267(14):9467–9469. [PubMed] [Google Scholar]
  59. Yura Y., Hayashi O., Kelly M., Oyasu R. Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions. Cancer Res. 1989 Mar 15;49(6):1548–1553. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES